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Abstract
Background: We present a case of asynchronously occurring adenocarcinomas 29 and 36 years after
ureterosigmoidostomy for bladder cancer, respectively, at both anastomosis sites.
Case presentation: A colonoscopy that was performed on a 69-year-old man because of bloody stool and an
elevated carcinoembryonic antigen (CEA) level revealed a polypoid lesion at the right ureterosigmoid anastomosis site
29 years after the patient’s ureterosigmoidostomy. Endoscopic resection was performed, and the lesion was diagnosed
as adenocarcinoma. Seven years later (36 years after ureterosigmoidostomy), an elevated lesion was detected at the left
ureterosigmoid anastomosis site by colonoscopy performed after detection of high CEA levels. Biopsy revealed
an adenocarcinoma that was immunohistologically positive for CDX2; sigmoidectomy and ureterectomy were
subsequently performed. The pathological diagnosis of the second tumor was adenocarcinoma arising in the
ureterosigmoid anastomosis site and invading the left ureter.
Conclusions: Diligent long-term follow-up of patients who underwent ureterosigmoidostomy is essential.
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Background
Ureterosigmoidostomy used to be commonly performed
to treat bladder cancer. However, the procedure was
recently abandoned because of complications such as
hyperchloremia, renal failure, urinary infection, and
adenocarcinoma at the ureterosigmoid anastomosis site.
We herein discuss a rare case of adenocarcinoma occurring
at both ureterosigmoid anastomosis sites; one was detected
29 years after the procedure while the other was detected
36 years afterwards.
Case presentation
A man underwent total cystectomy and ureterosigmoi-
dostomy at 40 years of age to treat his bladder cancer.
When he was 69 years old, he presented to our hospital
with bloody stools and elevated tumor marker levels
(carcinoembryonic antigen (CEA), 9.7 ng/mL). An elevated
lesion at the right anastomosis site of the ureterosigmoi-
dostomy was detected by colonoscopy (Fig. 1). Endoscopic
resection was performed whereupon tumor marker levels
decreased (CEA, 6.8 ng/mL). The pathological diagnosis
was intramucosal adenocarcinoma. After resection, follow-
up examinations were conducted using computed tom-
ography (CT) and endoscopy. For 6 years, the tumor
marker levels remained unchanged, and there was no
evidence of recurrence.
During a follow-up visit 7 years later, the patient’s
CEA level was found to be elevated (25.3 ng/mL), and
CT revealed a mass lesion at the left anastomosis site of
the ureterosigmoidostomy. On admission, his breathing
was deep and continuous (Kussmaul rhythm). Blood
tests indicated renal dysfunction, acidosis, and hyper-
chloremia (creatinine: 1.72 mg/dL; pH: 7.252; chloride:
112 mEq/L); this was thought to be caused by the prior
ureterosigmoidostomy and re-absorption of urine into
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the colon. The patient had bilateral hydronephrosis after
ureterosigmoidostomy, predominantly on the right side,
that had progressively worsened each year. His right
renal function was additionally compromised after the
endoscopic resection 7 years prior, and kidney function
had been monitored during follow-up hospital visits.
The renal failure upon admission was attributed to
urinary flow obstruction by the tumor. On emergency
admission, left nephrostomy was performed, which im-
proved the renal dysfunction and acidosis. In addition
to the mass lesion at the left anastomosis site, CT also
revealed left pyelectasis. Colonoscopy detected an ele-
vated lesion at the left anastomosis site, and biopsy re-
vealed well-differentiated tubular adenocarcinoma and
papillary adenocarcinoma (Fig. 2). Immunostaining was
CDX2-positive, indicating adenocarcinoma from the
intestinal epithelium. Thus, we diagnosed the patient
with sigmoid colon cancer at the left ureterosigmoid
anastomosis site. Sigmoidectomy and ureterectomy
with an ureterocutaneous fistula were performed (Figs. 3
and 4). Pathology revealed adenocarcinoma in the elevated
lesion at the ureterosigmoid anastomosis site and left
ureter (Figs. 5 and 6). The patient required an extended
hospital stay because of a postoperative catheter infection
and ileus that required 3 weeks of treatment. After the
27th postoperative day, kidney function was improved, and
the indwelling ureteral stent was removed. The patient
was discharged on the 32nd postoperative day.
Discussion
Ureterosigmoidostomy is a valid method for urinary di-
version, as it is not associated with urinary incontinence.
However, as exemplified by our patient, it is associated
with urinary infection, renal dysfunction, acidosis from
hyperchloremia, and colon cancer. In general, cancers
that develop at the anastomosis site of a ureterosigmoi-
dostomy tend to be one-sided. The patient in this case
developed cancer at both anastomosis sites, which is
rare. As such, this case highlights the importance of
careful follow-up examinations after ureterosigmoidost-
omy. Because the pathological margin of the endoscopic
resection was negative in our patient, the tumor at the
left anastomosis site was deemed to have developed
independently. The colon cancer was almost fatal for
this patient.
Carcinoma at the site of the ureterocolic anastomosis
was first reported in 1929 by Hammer [1]. Kälble et al.
reported that the occurrence of colon cancer in patients
who had undergone ureterosigmoidostomy was eight to
ten times higher than that in the general population [2].
Urdaneta et al. calculated that the incidence of carcin-
oma after ureterosigmoidostomy was 13,300 per 100,000
cases [3]. The mean lag period for the development of
colon carcinoma after surgery was 8.7 and 21.4 years for
patients who were over and under the age of 40 years at
the time of the operation, respectively [4]. The lesions
were reported to be distal to the ureterosigmoidostomy
site or involved the ureterocolonic junction [5]. Histo-
logical evaluations revealed the growth to be malignant
twice as often as it was benign, with adenocarcinoma of
the colon being the most frequent diagnosis [6].
The treatment for such tumors has changed over time.
In the 1970s, sigmoid colon cancer arising at anasto-
mosis sites after ureterosigmoidostomy was managed by
local extirpation of the lesion, with re-implantation of
one or both ureters back into the sigmoid. Currently, the
preferred treatment is either endoscopic resection or
Fig. 1 Intramucosal adenocarcinoma on the right anastomosis
site of the ureterosigmoidostomy. Endoscopic mucosal resection
was performed
Fig. 2 Submucosal adenocarcinoma on the left anastomosis site of
the ureterosigmoidostomy. Sigmoidectomy and ureterectomy with a
ureterocutaneous fistula were performed
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more extensive surgical resection of the involved bowel
segment combined with cutaneous loop diversions for
an obvious malignant lesion. In this case, the patient
opted for endoscopic therapy, and the right-sided
tumor at the anastomosis site was completely resected
endoscopically. However, the left-sided tumor was sus-
pected of being an infiltrating cancer; therefore, surgi-
cal resection was performed. Mortality from this type
of carcinoma is reportedly 33 % in cases of late detec-
tion that exhibit prominent metastases to regional
lymph nodes [6].
One theory to explain the carcinogenesis of colonic
carcinoma after ureterosigmoidostomy is the formation of
nitrosamines from bacterially reduced urinary nitrates and
from endogenous amines in feces and urine [2, 7–9]. An-
other theory is the urine-stool admixture concept, which
suggests that hydrolytic enzymes in the urine activate
conjugated carcinogens in the stool. These carcinogens
are most active at the junction of the two streams where
the greatest concentration exists [5, 10, 11]. Other factors,
such as chronic irritation of the bowel epithelium, instabil-
ity of the borderline between the urothelium and colonic
Fig. 3 Macroscopic appearance of the resected specimen. Elevated lesions at the ureterosigmoid anastomosis site can be observed
Fig. 4 The tumor at the anastomosis site. The tumor measured 55 × 32 mm in size
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epithelium, metabolic changes, and the presence of a fresh
colonic suture line may contribute to the induction of
colon carcinoma after ureterosigmoidostomy [2, 10–13].
Any one of these factors may be responsible for tumor
development in our patient. To detect cancer before it at-
tains advanced stage, surveillance colonoscopy should be
performed at regular intervals after ureterosigmoidostomy
because cancer or polyps can develop as early as 2 years
after surgery and progress over a few decades [6]. The
present case highlights the risk of cancer development
after ureterosigmoidostomy as well as the importance of
surveillance for early tumors. Based on the mechanism of
tumorigenesis after ureterosigmoidostomy, tumors can
develop either on the same or opposite side after resec-
tion, as in this case. Thus, follow-up examinations should
be performed judiciously and at short intervals.
Fig. 5 Microscopic findings (hematoxylin and eosin staining). Tumor tissue at the ureterosigmoid anastomosis site can be observed
Fig. 6 The left ureteral lumen was filled with tumor tissue
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Conclusions
We presented a case of adenocarcinomas occurring at
both anastomosis sites after ureterosigmoidostomy that
were detected 29 and 36 years after the original surgery,
respectively. Our experience suggests that adenocarcin-
oma at both anastomosis sites can occur asynchronously;
therefore, long-term attentive follow-up is necessary.
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